Recent developments in health and medicine span advancements in chronic disease treatments, surgical outcomes, and public health trends.

A first-in-class oral IL-23 peptide has demonstrated long-term safety and efficacy for patients with moderate-to-severe ulcerative colitis, offering a potential alternative to injectables.

The FDA has expanded the approval for Anktiva to include patients with BCG-unresponsive non-muscle invasive bladder cancer who have papillary-only tumors.

New research indicates that ear acupressure targeting the auricular vagus nerve can reduce rosacea severity and inflammatory biomarkers when used alongside standard treatments.

A Global Burden of Disease analysis reports that the global prevalence of acne vulgaris has risen by 63% since 1990, with cases expected to climb further through 2050.

The Royal College of Physicians is calling for the integration of training quality oversight into NHS board agendas following a survey where only 26% of residents felt prepared for their next career stage.

Patients undergoing lumbar spine surgery may experience lower rates of chronic postsurgical pain if they receive deep neuromuscular blockade compared to moderate blockade.

A study conducted in Botswana suggests that long-term antiretroviral therapy does not effectively reduce the risk of anogenital cancer in people living with HIV.

Evidence shows a clear correlation between substance use disorders involving cannabis, alcohol, or nicotine and an elevated risk for developing generalized anxiety disorder.